3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Magnetic Resonance Spectroscopy
18
pembrolizumab
16
Specimen Handling
15
Cisplatin
14
Carboplatin
9
Platinum
8
Cetuximab
8
1,2-diaminocyclohexaneplatinum II citrate
8
Radiotherapy, Intensity-Modulated
7
Radiation
7
Paclitaxel
7
Biopsy
7
Taxes
6
Radiotherapy
6
cemiplimab
4
X-Rays
4
Standard of Care
4
Nivolumab
4
Drug Therapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Ultrasonography
3
Surgical Procedures, Operative
3
Sentinel Lymph Node Biopsy
3
Observation
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
sargramostim
×
1 year
×
Clear all
No trials found.